USFDA Approval Venetoclax: Is It the Best Treatment Option?
USFDA approval Venetoclax marks a significant milestone for Alembic Pharmaceuticals.
Month: October 2026
Cancer drug price cap: Is it the worst deal for patients?
Cancer drug price cap: Discover how recent changes impact pricing for patients and access to medications.
Evonile Pharma Acquisition: The Smart Move for Growth
Evonile Pharma acquisition is a strategic step to enhance brand portfolio and market presence. Discover the implications and benefits.
USFDA Approval: Alembic Pharma’s Proven $110M Otic Solution
USFDA approval Alembic Pharma brings a new $110M otic suspension to market, ensuring safe treatment options.
Bliss GVS Pharma directors: Is this the best move for investors?
Bliss GVS Pharma directors are being proposed. Discover if this is a smart choice for shareholders.
Drug Price Caps: Right Move for Proven Affordability
Drug price caps are being sought in Karnataka for broader affordability beyond just cancer medicines.
Lupin FDA approval: Best Proven Injectable Emulsion
Lupin FDA approval marks a significant milestone in pharmaceutical advancements with Phytonadione Injectable Emulsion.
ICICI AMC stake acquisition: Is it the best move for investors?
ICICI AMC stake acquisition is a significant development in banking. Discover its implications for investors and the market.